Search

Author/Creator Hoos, Axel

2. Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study. Issue 2 (February 2020)

Authors:
Lonial, Sagar; Lee, Hans C; Badros, Ashraf; Trudel, Suzanne; Nooka, Ajay K; Chari, Ajai; Abdallah, Al-Ola; Callander, Natalie; Lendvai, Nikoletta; Sborov, Douglas; Suvannasankha, Attaya; Weisel, Katja; Karlin, Lionel; Libby, Edward; Arnulf, Bertrand; Facon, Thierry; Hulin, Cyrille; Kortüm, K Mart...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 2(2020)
Page Start:
207
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Immunodynamics of explanted human tumors for immuno‐oncology. Issue 1 (29th December 2020)

Authors:
Dubuisson, Agathe; Fahrner, Jean‐Eudes; Goubet, Anne‐Gaëlle; Terrisse, Safae; Voisin, Nicolas; Bayard, Charles; Lofek, Sebastien; Drubay, Damien; Bredel, Delphine; Mouraud, Séverine; Susini, Sandrine; Cogdill, Alexandria; Rebuffet, Lucas; Ballot, Elise; Jacquelot, Nicolas; Thomas de Montpreville,...
Journal:
EMBO molecular medicine
Issue:
Volume 13:Issue 1(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial. Issue 5 (May 2015)

Authors:
Eggermont, Alexander M M; Chiarion-Sileni, Vanna; Grob, Jean-Jacques; Dummer, Reinhard; Wolchok, Jedd D; Schmidt, Henrik; Hamid, Omid; Robert, Caroline; Ascierto, Paolo A; Richards, Jon M; Lebbé, Céleste; Ferraresi, Virginia; Smylie, Michael; Weber, Jeffrey S; Maio, Michele; Konto, Cyril; Hoos, A...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 5(2015:May)
Page Start:
522
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma. (17th June 2013)

Authors:
Wolchok, Jedd D.; Hodi, F. Stephen; Weber, Jeffrey S.; Allison, James P.; Urba, Walter J.; Robert, Caroline; O'Day, Steven J.; Hoos, Axel; Humphrey, Rachel; Berman, David M.; Lonberg, Nils; Korman, Alan J.
Journal:
Annals of the New York Academy of Sciences
Issue:
Volume 1291(2013)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Targeting B-cell maturation antigen with GSK2857916 antibody–drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial. Issue 12 (December 2018)

Authors:
Trudel, Suzanne; Lendvai, Nikoletta; Popat, Rakesh; Voorhees, Peter M; Reeves, Brandi; Libby, Edward N; Richardson, Paul G; Anderson, Larry D; Sutherland, Heather J; Yong, Kwee; Hoos, Axel; Gorczyca, Michele M; Lahiri, Soumi; He, Zangdong; Austin, Daren J; Opalinska, Joanna B; Cohen, Adam D
Journal:
Lancet oncology
Issue:
Volume 19:Issue 12(2018)
Page Start:
1641
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1). Issue 3 (16th March 2023)

Authors:
Postel-Vinay, Sophie; Lam, Vincent K; Ros, Willeke; Bauer, Todd M; Hansen, Aaron R; Cho, Daniel C; Stephen Hodi, F; Schellens, Jan H M; Litton, Jennifer K; Aspeslagh, Sandrine; Autio, Karen A; Opdam, Frans L; McKean, Meredith; Somaiah, Neeta; Champiat, Stephane; Altan, Mehmet; Spreafico, Anna; Ra...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 11:Issue 3(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗